Mieke Versluis

1.4k citations
38 papers · 1.1k · h-index 18

Impact in

  • Ophthalmology top 0.5%
    • Ocular Oncology and Treatments
  • Immunology top 5%
    • Immunotherapy and Immune Responses
    • Immune cells in cancer
    • Immune Cell Function and Interaction

Papers in

  • Ophthalmology 23
    • Ocular Oncology and Treatments 23
  • Immunology 11
    • Immunotherapy and Immune Responses 7
    • T-cell and B-cell Immunology 3
    • Immune Cell Function and Interaction 3
    • Immune cells in cancer 3
Co-authors
Martine J. Jager (23 shared papers)Gregorius P. M. Luyten (17 shared papers)Pieter A. van der Velden (22 shared papers)Long V. Ly (5 shared papers)Inge H. G. Bronkhorst (6 shared papers)Ekaterina S. Jordanova (4 shared papers)Thorbald van Hall (7 shared papers)J. Vrolijk (3 shared papers)
Journals
Cancers (5 papers)Investigative Ophthalmology & Visual Science (5 papers)PLoS ONE (4 papers)Journal of Molecular Diagnostics (2 papers)Scientific Reports (2 papers)
Partner nations
NetherlandsUnited StatesAustralia

In The Last Decade

Mieke Versluis

38 papers receiving 1.0k citations

Peers

Mieke Versluis
Comparison fields: 5 of 71
  • Ophthalmology 636
  • Immunology 407
  • Oncology 238
  • Molecular Biology 303
  • Cancer Research 59
Replace Gaia Barisione with:
Gaia Barisione Italy
Chikako Yamamoto Japan
Kimberly M. Komatsubara United States
Francesco Lanza Italy
Jolanda Vaarwater Netherlands
Sanja Pajovic Canada
Michael H. Neale United Kingdom
Shankar K. Nayak United States
Gabriele Prescher Germany
Tobias Schimming Germany
Mieke Versluis relative to Gaia Barisione Italy Gaia Barisione's profile →
Citations per field
00.5×2×3.0×
Gaia Barisione · 1×
Citations per year

Countries citing papers authored by Mieke Versluis

Since Specialization
Citations

This map shows the geographic impact of Mieke Versluis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mieke Versluis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mieke Versluis more than expected).

Fields of papers citing papers by Mieke Versluis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mieke Versluis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mieke Versluis. The network helps show where Mieke Versluis may publish in the future.

Co-authors

The 25 scholars most cited alongside Mieke Versluis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mieke Versluis Line = papers co-authored together Mieke Versluis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Detection of M2-Macrophages in Uveal Melanoma and Relation with Survival
Investigative Ophthalmology & Visual Science ·Inge H. G. Bronkhorst, Long V. Ly, Ekaterina S. Jordanova, J. Vrolijk, Mieke Versluis, Gregorius P. M. Luyten, Martine J. Jager
2010173
2
Prognostic parameters in uveal melanoma and their association with BAP1 expression
British Journal of Ophthalmology ·T. Huibertus van Essen, Sake I. van Pelt, Mieke Versluis, Inge H. G. Bronkhorst, Sjoerd G. van Duinen, Marina Marinkovic, Wilma G. M. Kroes, Claudia Ruivenkamp, Shruti Shukla, Annelies de Klein, Emine Kılıç, J. William Harbour, Gregorius P. M. Luyten, Pieter A. van der Velden, Robert M. Verdijk, Martine J. Jager
201499
3
Digital PCR Validates 8q Dosage as Prognostic Tool in Uveal Melanoma
PLoS ONE ·Mieke Versluis, Mark J. de Lange, Sake I. van Pelt, Claudia Ruivenkamp, Wilma G. M. Kroes, Jinfeng Cao, Martine J. Jager, Gré P.M. Luyten, Pieter A. van der Velden
201585
4
In Aged Mice, Outgrowth of Intraocular Melanoma Depends on Proangiogenic M2-Type Macrophages
The Journal of Immunology ·Long V. Ly, Aabed Baghat, Mieke Versluis, Ekaterina S. Jordanova, Gregorius P. M. Luyten, Nico van Rooijen, Thorbald van Hall, Pieter A. van der Velden, Martine J. Jager
201074
5
Upregulation of HLA Expression in Primary Uveal Melanoma by Infiltrating Leukocytes
PLoS ONE ·T. Huibertus van Essen, Sake I. van Pelt, Inge H. G. Bronkhorst, Mieke Versluis, Fariba Némati, Cécile Laurent, Gregorius P. M. Luyten, Thorbald van Hall, Peter J. van den Elsen, Pieter A. van der Velden, Didier Decaudin, Martine J. Jager
201664
6
Inhibition of CSF-1R Supports T-Cell Mediated Melanoma Therapy
PLoS ONE ·Marjolein Sluijter, Tetje C. van der Sluis, Pieter A. van der Velden, Mieke Versluis, Brian L. West, Sjoerd H. van der Burg, Thorbald van Hall
201451
7
Inflammatory Cytokines in Eyes with Uveal Melanoma and Relation with Macrophage Infiltration
Investigative Ophthalmology & Visual Science ·Long V. Ly, Inge H. G. Bronkhorst, Els van Beelen, J. Vrolijk, Andrew W. Taylor, Mieke Versluis, Gregorius P. M. Luyten, Martine J. Jager
201047
8
Heterogeneity revealed by integrated genomic analysis uncovers a molecular switch in malignant uveal melanoma
Oncotarget ·Mark J. de Lange, Sake I. van Pelt, Mieke Versluis, Ekaterina S. Jordanova, Wilma G. M. Kroes, Claudia Ruivenkamp, Sjoerd H. van der Burg, Gregorius P. M. Luyten, Thorbald van Hall, Martine J. Jager, Pieter A. van der Velden
201541
9
Peptide Vaccination after T-Cell Transfer Causes Massive Clonal Expansion, Tumor Eradication, and Manageable Cytokine Storm
Cancer Research ·Long V. Ly, Marjolein Sluijter, Mieke Versluis, Gré P.M. Luyten, Sjoerd H. van der Burg, Cornelis J.M. Melief, Martine J. Jager, Thorbald van Hall
201040
10
Loss of MAPK Pathway Activation in Post-Mitotic Retinal Cells as Mechanism in MEK Inhibition-Related Retinopathy in Cancer Patients
Medicine ·Elon H. C. van Dijk, Danique E. M. Duits, Mieke Versluis, Gregrorius P. M. Luyten, Arthur A. Bergen, Ellen Kapiteijn, Mark J. de Lange, Camiel J. F. Boon, Pieter A. van der Velden
201634
11
Distribution of GNAQ and GNA11 Mutation Signatures in Uveal Melanoma Points to a Light Dependent Mutation Mechanism
PLoS ONE ·Mark J. de Lange, Lubna Razzaq, Mieke Versluis, Sven Verlinde, Mehmet Doğrusöz, Stefan Böhringer, Marina Marinkovic, Gregorius P. M. Luyten, R. J. W. De Keizer, Frank R. de Gruijl, Martine J. Jager, Pieter A. van der Velden
201534
12
Digital PCR-Based T-cell Quantification–Assisted Deconvolution of the Microenvironment Reveals that Activated Macrophages Drive Tumor Inflammation in Uveal Melanoma
Molecular Cancer Research ·Mark J. de Lange, Rogier J. Nell, Rajshri N. Lalai, Mieke Versluis, Ekaterina S. Jordanova, Gré P.M. Luyten, Martine J. Jager, Sjoerd H. van der Burg, Willem H. Zoutman, Thorbald van Hall, Pieter A. van der Velden
201833
13
Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution
Cancers ·Niels J. Brouwer, Gülçin Gezgin, Annemijn P. A. Wierenga, Inge H. G. Bronkhorst, Marina Marinkovic, Gregorius P. M. Luyten, Mieke Versluis, Wilma G. M. Kroes, Pieter A. van der Velden, Robert M. Verdijk, Martine J. Jager
201928
14
HDAC Inhibition Increases HLA Class I Expression in Uveal Melanoma
Cancers ·Zahra Souri, Aart G. Jochemsen, Mieke Versluis, Annemijn P. A. Wierenga, Fariba Némati, Pieter A. van der Velden, Wilma G. M. Kroes, Robert M. Verdijk, Gregorius P. M. Luyten, Martine J. Jager
202028
15
Bevacizumab and intraocular tumors: an intriguing paradox.
PubMed ·Mariam el Filali, Long V. Ly, Gregorius P. M. Luyten, Mieke Versluis, Hans E. Grossniklaus, Pieter A. van der Velden, Martine J. Jager
201227
16
Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma
BMC Cancer ·Rogier J. Nell, Nino V. Menger, Mieke Versluis, Gregorius P. M. Luyten, Robert M. Verdijk, Michele C. Madigan, Martine J. Jager, Pieter A. van der Velden
202125
17
Radiation Treatment Affects Chromosome Testing in Uveal Melanoma
Investigative Ophthalmology & Visual Science ·Mehmet Doğrusöz, Wilma G. M. Kroes, Sjoerd G. van Duinen, Carien L. Creutzberg, Mieke Versluis, Jaco C. Bleeker, Marina Marinkovic, Gregorius P. M. Luyten, Martine J. Jager
201522
18
Role of Adenosine Receptors in the Treatment of Asthma and Chronic Obstructive Pulmonary Disease
Drugs in R&D ·Maarten van den Berge, Machteld N. Hylkema, Mieke Versluis, Dirkje S. Postma
200718
19
Accurate Quantification of T Cells by Measuring Loss of Germline T-Cell Receptor Loci with Generic Single Duplex Droplet Digital PCR Assays
Journal of Molecular Diagnostics ·Willem H. Zoutman, Rogier J. Nell, Mieke Versluis, Debby van Steenderen, Rajshri N. Lalai, Jacoba J. Out‐Luiting, Mark J. de Lange, Maarten H. Vermeer, Anton W. Langerak, Pieter A. van der Velden
201616
20
Ischemia Is Related to Tumour Genetics in Uveal Melanoma
Cancers ·Niels J. Brouwer, Annemijn P. A. Wierenga, Gülçin Gezgin, Marina Marinkovic, Gregorius P. M. Luyten, Wilma G. M. Kroes, Mieke Versluis, Pieter A. van der Velden, Robert M. Verdijk, Martine J. Jager
201916

About Mieke Versluis

Mieke Versluis is a scholar working on Ophthalmology, Immunology, Molecular Biology, Oncology and Pulmonary and Respiratory Medicine, having authored 38 papers that have together received 1.1k indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (23 papers), Immunotherapy and Immune Responses (7 papers), Retinal Development and Disorders (6 papers), CAR-T cell therapy research (5 papers), T-cell and B-cell Immunology (3 papers), Immune Cell Function and Interaction (3 papers), Immune cells in cancer (3 papers) and Cutaneous Melanoma Detection and Management (2 papers). The work is most often cited by research in Ophthalmology (636 citations), Immunology (407 citations), Oncology (238 citations), Molecular Biology (303 citations) and Cancer Research (59 citations). Mieke Versluis has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Martine J. Jager, Gregorius P. M. Luyten, Pieter A. van der Velden, Long V. Ly, Inge H. G. Bronkhorst, Ekaterina S. Jordanova, Thorbald van Hall, J. Vrolijk, Wilma G. M. Kroes and Mark J. de Lange. Their work appears in journals such as Cancers, Investigative Ophthalmology & Visual Science, PLoS ONE, Journal of Molecular Diagnostics and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gaia BarisioneBreakdown of academic impact, for papers by Chikako YamamotoBreakdown of academic impact, for papers by Kimberly M. KomatsubaraBreakdown of academic impact, for papers by Francesco LanzaBreakdown of academic impact, for papers by Jolanda VaarwaterBreakdown of academic impact, for papers by Sanja PajovicBreakdown of academic impact, for papers by Michael H. NealeBreakdown of academic impact, for papers by Shankar K. NayakBreakdown of academic impact, for papers by Gabriele PrescherBreakdown of academic impact, for papers by Tobias Schimming